Meiji Yasuda Life Insurance Co Lowers Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Meiji Yasuda Life Insurance Co reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 7.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,435 shares of the company’s stock after selling 590 shares during the quarter. Meiji Yasuda Life Insurance Co’s holdings in HCA Healthcare were worth $2,389,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in HCA. CreativeOne Wealth LLC purchased a new stake in HCA Healthcare in the first quarter valued at approximately $231,000. New Mexico Educational Retirement Board raised its position in shares of HCA Healthcare by 29.9% in the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after buying an additional 3,200 shares during the period. Sanders Capital LLC grew its position in HCA Healthcare by 4.2% during the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after acquiring an additional 456,738 shares during the period. KBC Group NV raised its holdings in shares of HCA Healthcare by 60.6% in the 4th quarter. KBC Group NV now owns 365,984 shares of the company’s stock worth $99,065,000 after purchasing an additional 138,146 shares during the period. Finally, Kingswood Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the 1st quarter worth about $566,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 1.5 %

NYSE HCA opened at $397.50 on Wednesday. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The company has a 50-day simple moving average of $365.55 and a 200-day simple moving average of $339.06. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $404.90. The firm has a market capitalization of $104.11 billion, a PE ratio of 19.82, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the prior year, the business earned $4.29 EPS. The firm’s revenue was up 10.3% on a year-over-year basis. On average, equities analysts forecast that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.66%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock valued at $6,407,273 over the last 90 days. 1.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms have issued reports on HCA. Robert W. Baird initiated coverage on shares of HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective for the company. Oppenheimer boosted their price objective on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a report on Monday, August 19th. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Truist Financial raised their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $359.89.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.